Seven Eight Capital’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-12,524
Closed -$854K 736
2024
Q1
$854K Sell
12,524
-17,032
-58% -$1.16M 0.09% 332
2023
Q4
$1.85M Buy
29,556
+13,377
+83% +$837K 0.21% 139
2023
Q3
$734K Buy
+16,179
New +$734K 0.09% 309
2022
Q4
Sell
-8,362
Closed -$546K 450
2022
Q3
$546K Buy
+8,362
New +$546K 0.11% 258